Call Options

27 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $6.06 Million - $6.87 Million
-126,300 Reduced 99.92%
100 $0
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $2.59 Million - $3.09 Million
53,400 Added 73.15%
126,400 $54,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $4.12 Million - $4.6 Million
71,100 Added 3742.11%
73,000 $22,000
Q2 2023

Jul 18, 2023

SELL
$63.71 - $70.74 $165,646 - $183,924
-2,600 Reduced 57.78%
1,900 $2,000
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $6.75 Million - $7.66 Million
-102,800 Reduced 95.81%
4,500 $4,000
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $458,816 - $543,303
6,700 Added 6.66%
107,300 $791,000
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $2,444 - $1.44 Million
-18,800 Reduced 15.75%
100,600 $840,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $21 Million - $23.2 Million
-289,500 Reduced 70.8%
119,400 $1.46 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $23.3 Million - $28 Million
379,200 Added 1276.77%
408,900 $796,000
Q4 2021

Jan 18, 2022

SELL
$53.63 - $62.52 $2.36 Million - $2.75 Million
-44,000 Reduced 59.7%
29,700 $16,000
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $940,803 - $1.1 Million
-15,900 Reduced 17.75%
73,700 $27,000
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $2.8 Million - $3.05 Million
45,300 Added 102.26%
89,600 $77,000
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $5.31 Million - $5.97 Million
-89,500 Reduced 66.89%
44,300 $57,000
Q4 2020

Jan 21, 2021

BUY
$57.74 - $65.43 $1.25 Million - $1.41 Million
21,600 Added 19.25%
133,800 $88,000
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $4.83 Million - $5.35 Million
-84,100 Reduced 42.84%
112,200 $333,000
Q2 2020

Jul 22, 2020

SELL
$54.82 - $64.09 $8.85 Million - $10.3 Million
-161,400 Reduced 45.12%
196,300 $1.17 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $969,760 - $1.41 Million
-20,900 Reduced 5.52%
357,700 $403,000
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $8.96 Million - $11.7 Million
182,000 Added 92.57%
378,600 $569,000
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $354,991 - $420,893
8,300 Added 4.41%
196,600 $496,000
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $14.4 Million - $16 Million
-323,800 Reduced 63.23%
188,300 $175,000
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $19.5 Million - $23.3 Million
432,200 Added 540.93%
512,100 $156,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $2.23 Million - $2.89 Million
-45,700 Reduced 36.39%
79,900 $23,000
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $6.3 Million - $7.1 Million
114,100 Added 992.17%
125,600 $876,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $3.53 Million - $4.4 Million
-69,900 Reduced 85.87%
11,500 $24,000
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $3.87 Million - $4.46 Million
64,600 Added 384.52%
81,400 $159,000
Q4 2017

Jan 17, 2018

SELL
$59.94 - $65.35 $1.37 Million - $1.49 Million
-22,800 Reduced 57.58%
16,800 $34,000
Q3 2017

Oct 17, 2017

BUY
$55.23 - $63.74 $2.19 Million - $2.52 Million
39,600
39,600 $173,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.